Showing results (51-60 of 59) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Circulation. Cardiovascular Quality and Outcomes|August 20, 2020
Transcatheter Aortic Valve Replacement in Low-Population Density Areas: Assessing Healthcare Access for Older Adults With Severe Aortic StenosisAbdulla A Damluji, Michael Fabbro, Richard H Epstein, et al.Journal of the American College of Cardiology|February 4, 2022
Interventions for Frailty Among Older Adults With Cardiovascular Disease: JACC State-of-the-Art ReviewNaila Ijaz, Brian Buta, Qian-Li Xue, et al.JACC. Cardiovascular Imaging|November 19, 2018
Self-Expanding Transcatheter Aortic Valve Replacement in Patients With Low-Gradient Aortic StenosisStanley J Chetcuti, G Michael Deeb, Jeffrey J Popma, et al.Circulation|November 13, 2020
Myocardial Injury in Severe COVID-19 Compared With Non-COVID-19 Acute Respiratory Distress SyndromeThomas S Metkus, Lori J Sokoll, Andreas S Barth, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|July 4, 2018
Alternative access for transcatheter aortic valve replacement in older adults: A collaborative study from France and United StatesAbdulla A Damluji, Magdalena Murman, Seunghwan Byun, et al.American Heart Journal|June 23, 2007
Peroxisome proliferator-activated receptor gamma agonists for the Prevention of Adverse events following percutaneous coronary Revascularization--results of the PPAR studyDeepak L Bhatt, Derek P Chew, Cindy Grines, et al.Journal of the American College of Cardiology|June 10, 2015
2-Year Outcomes in Patients Undergoing Surgical or Self-Expanding Transcatheter Aortic Valve ReplacementMichael J Reardon, David H Adams, Neal S Kleiman, et al.Journal of the American College of Cardiology|March 4, 2022
2-Year Outcomes After Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk PatientsJohn K Forrest, G Michael Deeb, Steven J Yakubov, et al.JAMA Cardiology|August 20, 2016
Outcomes in the Randomized CoreValve US Pivotal High Risk Trial in Patients With a Society of Thoracic Surgeons Risk Score of 7% or LessMichael J Reardon, Neal S Kleiman, David H Adams, et al.Pageof 6